1. A 5-Pathway Signature Predicts Prognosis Based on Immune-Derived lncRNAs in Patients with Breast Cancer. (12th December 2022) Authors: Liu, Bo; Zhu, Nian; Huo, Huixia; Long, Junqi; Ji, Xinchan; Li, Jinmeng; Zhuang, Xujie; Wang, Huina; Li, Lujia; Chen, Yuhaoran; Yang, Wei; Zhao, Shuangtao Other Names: Qin Shuanglin Academic Editor. Journal: Journal of oncology Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A gastric cancer recognition algorithm on gastric pathological sections based on multistage attention‐DenseNet. (18th March 2021) Authors: Liu, Bo; Zhao, Yelong; Yang, Bin; Zhao, Shuangtao; Gu, Rentao; Gahegan, Mark Journal: Concurrency and computation Issue: Volume 33:Number 10(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical significance and functional validation of PPA1 in various tumors. (26th September 2016) Authors: Luo, Dehong; Wang, Guanwen; Shen, Wenzhi; Zhao, Shuangtao; Zhou, Wei; Wan, Lin; Yuan, Liying; Yang, Shuang; Xiang, Rong Journal: Cancer medicine Issue: Volume 5:Number 10(2016:Oct.) Page Start: 2800 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cover Image. (20th February 2019) Authors: Zhao, Shuangtao; Shen, Wenzhi; Du, Renle; Luo, Xiaohe; Yu, Jiangyong; Zhou, Wei; Dong, Xiaoli; Gao, Ruifang; Wang, Chaobin; Yang, Houpu; Wang, Shu Journal: Cancer medicine Issue: Volume 8:Number 2(2019:Feb.) Page Start: i Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) ‐ outcomes and mutation profile from venetoclax resistant MCL patients. Issue 6 (17th April 2020) Authors: Zhao, Shuangtao; Kanagal‐Shamanna, Rashmi; Navsaria, Lucy; Ok, Chi Young; Zhang, Shaojun; Nomie, Krystle; Han, Guangchun; Hao, Dapeng; Hill, Holly A.; Jiang, Changying; Yao, Yixin; Nastoupil, Loretta; Westin, Jason; Fayad, Luis; Nair, Ranjit; Steiner, Raphel; Ahmed, Sairah; Samaniego, Felipe; Iye... Journal: American journal of hematology Issue: Volume 95:Issue 6(2020:Jun.) Page Start: 623 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Establishment and validation of a multigene model to predict the risk of relapse in hormone receptor-positive early-stage Chinese breast cancer patients. Issue 2 (7th November 2022) Authors: Liu, Jiaxiang; Zhao, Shuangtao; Yang, Chenxuan; Ma, Li; Wu, Qixi; Meng, Xiangzhi; Zheng, Bo; Guo, Changyuan; Feng, Kexin; Shang, Qingyao; Liu, Jiaqi; Wang, Jie; Zhang, Jingbo; Shan, Guangyu; Xu, Bing; Liu, Yueping; Ying, Jianming; Wang, Xin; Wang, Xiang Editors: Hao, Xiuyuan; Jia, Rongman Journal: Chinese medical journal Issue: Volume 136:Issue 2(2023) Page Start: 184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Four‐gene signature based on machine learning filtration could predict prognosis of patients with breast cancer. Issue 2 (31st October 2022) Authors: Liu, Bo; Wang, Huina; Wang, Xin; Long, Junqi; Zhuang, Xujie; Ji, Xinchan; Zhu, Nian; Li, Jinmeng; Gao, Ting; Zhang, Xuehui; Yu, Jiangyong; Zhao, Shuangtao Other Names: Yu Hui guestEditor. Journal: Expert systems Issue: Volume 40:Issue 2(2023) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma. Issue 2 (10th January 2022) Authors: Jain, Preetesh; Zhao, Shuangtao; Lee, Hun Ju; Hill, Holly A.; Ok, Chi Young; Kanagal-Shamanna, Rashmi; Hagemeister, Fredrick B.; Fowler, Nathan; Fayad, Luis; Yao, Yixin; Liu, Yang; Moghrabi, Omar B.; Navsaria, Lucy; Feng, Lei; Nogueras Gonzalez, Graciela M.; Xu, Guofan; Thirumurthi, Selvi; Santos... Journal: Journal of clinical oncology Issue: Volume 40:Issue 2(2022) Page Start: 202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Ibrutinib–rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial. Issue 3 (March 2022) Authors: Wang, Michael L; Jain, Preetesh; Zhao, Shuangtao; Lee, Hun Ju; Nastoupil, Loretta; Fayad, Luis; Ok, Chi Young; Kanagal-Shamanna, Rashmi; Hill, Holly A; Yao, Yixin; Hagemeister, Fredrick B; Westin, Jason R; Fowler, Nathan; Samaniego, Felipe; Steiner, Raphael; Nair, Ranjit; Iyer, Swaminathan P; Nav... Journal: Lancet oncology Issue: Volume 23:Issue 3(2022) Page Start: 406 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. ICAM3 mediates inflammatory signaling to promote cancer cell stemness. (28th May 2018) Authors: Shen, Wenzhi; Xie, Junling; Zhao, Shuangtao; Du, Renle; Luo, Xiaohe; He, Huiwen; Jiang, Shan; Hao, Na; Chen, Chong; Guo, Chunlei; Liu, Yanhua; Chen, Yanan; Sun, Peiqing; Yang, Shengyong; Luo, Na; Xiang, Rong; Luo, Yunping Journal: Cancer letters Issue: Volume 422(2018) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗